F
Fengjuan Chen
Researcher at Guangzhou Medical University
Publications - 9
Citations - 497
Fengjuan Chen is an academic researcher from Guangzhou Medical University. The author has contributed to research in topics: Viral load & Interquartile range. The author has an hindex of 5, co-authored 9 publications receiving 324 citations.
Papers
More filters
Journal ArticleDOI
Viral dynamics in asymptomatic patients with COVID-19.
TL;DR: It is demonstrated that although they have a lower viral load, APs with COVID-19 still have certain period of viral shedding, which suggests the possibility of transmission during their asymptomatic period.
Journal ArticleDOI
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China
Cai Qingxian,Fengjuan Chen,Luo Fang,Liu Xiaohui,Wang Tao,Wu Qikai,He Qing,Wang Zhaoqin,Yingxia Liu,Chen Jun,Liu Lei,Xu Lin +11 more
TL;DR: This is the first study showing that obesity, especially in men, significantly increases the risk of developing severe pneumonia in COVID-19 patients, and clinicians should maintain a high level of attention in obese patients.
Journal ArticleDOI
Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery.
Chengqian Feng,Jingrong Shi,Qinghong Fan,Yaping Wang,Huang Huang,Fengjuan Chen,Guofang Tang,Youxia Li,Pingchao Li,Jiaojiao Li,Jianping Cui,Liliangzi Guo,Liliangzi Guo,Sisi Chen,Sisi Chen,Mengling Jiang,Liqiang Feng,Ling Chen,Ling Chen,Chunliang Lei,Changwen Ke,Xilong Deng,Fengyu Hu,Xiaoping Tang,Feng Li +24 more
TL;DR: In this article, the authors report the kinetics of the SARS-CoV-2 specific immune response in 204 individuals up to 1-year after recovery from COVID-19.
Journal ArticleDOI
Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study.
Jiazhen Zheng,Rui Zhou,Fengjuan Chen,Guofang Tang,Keyi Wu,Fu-Rong Li,Huamin Liu,Jianyun Lu,Jiyuan Zhou,Ziying Yang,Yuxin Yuan,Chunliang Lei,Xian-Bo Wu +12 more
TL;DR: RP events occurred in nearly 10% of COVID-19 patients shortly after the negative tests, were not associated with worsening symptoms and unlikely reflect reinfection, and patients’ lack of efficiency in virus clearance was a risk factor for RP result.
Journal ArticleDOI
Prognostic roles of KL-6 in disease severity and lung injury in COVID-19 patients: A longitudinal retrospective analysis.
Kai Deng,Qinghong Fan,Yanhong Yang,Xizi Deng,Ruiying He,Yizhou Tan,Yun Lan,Xilong Deng,Yuejun Pan,Yaping Wang,Yujuan Guan,Huiyuan Liu,Fengjuan Chen,Xiaoneng Mo,Xinghua Tan,Chun Luo,Xueliang Wen,Ying Liu,Jinxin Liu,Lieguang Zhang,Xiaoping Tang,Fengyu Hu,Feng Li +22 more
TL;DR: In this paper, the authors investigated the dynamic changes of Krebs von den Lungen-6 (KL-6) among patients with coronavirus disease 2019 (COVID-19) and the role of KL-6 as a noninvasive biomarker for predicting long-term lung injury.